During the past decade, Hospital de Conxo conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital de Conxo" are "Hypertension" (2 trials), "Asthma" (1 trials), "Diabetes Mellitus Type 2" (1 trials), "Rhinitis" (1 trials) and "Rhinoconjunctivitis" (1 trials). Many other conditions were trialed in "Hospital de Conxo" in a lesser frequency.

Most popular intervention types in "Hospital de Conxo" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "DP/MG/14-1" (1 trials), "DP/MG/14-2" (1 trials), "Fixed dose combination telmisartan 80 mg + HCTZ 12.5 mg" (1 trials), "Fixed dose combination telmisartan 80 mg + HCTZ 25 mg" (1 trials) and "Inhaled Insulin (Exubera)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Conxo" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hospital de Conxo". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital de Conxo, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Conxo, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".